Richmond Vivek Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.01 Cr
as on 20-12-2024
- Paid Up Capital ₹ 1.01 Cr
as on 20-12-2024
- Company Age 18 Year, 5 Months
- Last Filing with ROC 31 Mar 2014
- Open Charges ₹ 8.40 M
as on 20-12-2024
- Satisfied Charges ₹ 1.00 Cr
as on 20-12-2024
About Richmond Vivek Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2014. It's a company limited by shares with an authorized capital of Rs 1.01 Cr and a paid-up capital of Rs 1.01 Cr.
The company currently has active open charges totaling ₹8.40 M. The company has closed loans amounting to ₹1.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sudhir Srivastava, Tripti Srivastava, and Santhosh Kaleru serve as directors at the Company.
- CIN/LLPIN
U24231TG2006PTC050846
- Company No.
050846
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Aug 2006
- Date of AGM
29 Sep 2014
- Date of Balance Sheet
31 Mar 2014
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Richmond Vivek Laboratories?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sudhir Srivastava  | Director | 09-Aug-2006 | Current |
| Tripti Srivastava | Director | 07-May-2019 | Current |
| Santhosh Kaleru | Director | 26-Jun-2015 | Current |
Financial Performance of Richmond Vivek Laboratories.
Enhance accessibility to Richmond Vivek Laboratories's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Richmond Vivek Laboratories?
Unlock access to Richmond Vivek Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Richmond Biosciences Private LimitedActive 35 years 11 monthsSudhir Srivastava and Tripti Srivastava are mutual person
Charges (Loans)
₹0.84 Cr
₹1.00 Cr
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.84 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Mar 2012 | State Bank Of India | ₹7.50 M | Open |
| 27 Sep 2007 | State Bank Of India | ₹0.90 M | Open |
| 26 Jul 2007 | State Bank Of India | ₹1.00 Cr | Satisfied |
How Many Employees Work at Richmond Vivek Laboratories?
Richmond Vivek Laboratories has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Richmond Vivek Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Richmond Vivek Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
